COVID-19 mRNA vaccines can induce myocarditis and pericarditis, predominantly in males (85.5%), with symptoms typically appearing within a few days after the second dose and most patients recovering fully.
Myocarditis is an inflammatory condition of the myocardium that develops secondary to various etiological factors; it is a disease with complications and mortality. Although the causes are infectious, immune-mediated, and drug-toxin exposure, it can also develop after exposed to the coronavirus 2 and coronavirus disease 2019 (COVID-19) vaccines, which recently affected the world and caused severe acute respiratory syndrome. In addition to clinical and laboratory findings, imaging methods, such as echocardiography, computed tomography angiography, and cardiac magnetic resonance imaging, play a significant role in diagnosis. In this article, myocarditis overview, diagnostic methods, post-COVID, and post-vaccine myocarditis were reviewed.
Sasani et al. (2022) conducted a review in COVID-19 mRNA vaccine-induced myocarditis. COVID-19 mRNA vaccines was evaluated. COVID-19 mRNA vaccines can induce myocarditis and pericarditis, predominantly in males (85.5%), with symptoms typically appearing within a few days after the second dose and most patients recovering fully.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: